Entering text into the input field will update the search result below

TELA Bio readies IPO

Oct. 16, 2019 10:55 AM ETTELA Bio, Inc. (TELA)TELABy: Douglas W. House, SA News Editor
  • TELA Bio (TELA) has filed a preliminary prospectus for a $69M IPO.
  • The Malvern, PA-based med tech firm develops tissue reinforcement materials, branded as OviTex, used in soft tissue reconstruction, including hernia repair, abdominal wall reconstruction and plastic/reconstruction surgery. They are currently cleared for sale in the U.S. and have been sold here since July 2016.
  • 2019 Financials (6 mo.): Revenue: $6.6M (+83%); Operating Expenses: $13.2M (+28%); Net Loss: ($16.0M) (+15%); Cash Flow Ops: ($13.0M) (-20%).

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.